» Articles » PMID: 19688045

Sleep-disordered Breathing and Mortality: a Prospective Cohort Study

Overview
Journal PLoS Med
Specialty General Medicine
Date 2009 Aug 19
PMID 19688045
Citations 583
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Sleep-disordered breathing is a common condition associated with adverse health outcomes including hypertension and cardiovascular disease. The overall objective of this study was to determine whether sleep-disordered breathing and its sequelae of intermittent hypoxemia and recurrent arousals are associated with mortality in a community sample of adults aged 40 years or older.

Methods And Findings: We prospectively examined whether sleep-disordered breathing was associated with an increased risk of death from any cause in 6,441 men and women participating in the Sleep Heart Health Study. Sleep-disordered breathing was assessed with the apnea-hypopnea index (AHI) based on an in-home polysomnogram. Survival analysis and proportional hazards regression models were used to calculate hazard ratios for mortality after adjusting for age, sex, race, smoking status, body mass index, and prevalent medical conditions. The average follow-up period for the cohort was 8.2 y during which 1,047 participants (587 men and 460 women) died. Compared to those without sleep-disordered breathing (AHI: <5 events/h), the fully adjusted hazard ratios for all-cause mortality in those with mild (AHI: 5.0-14.9 events/h), moderate (AHI: 15.0-29.9 events/h), and severe (AHI: >or=30.0 events/h) sleep-disordered breathing were 0.93 (95% CI: 0.80-1.08), 1.17 (95% CI: 0.97-1.42), and 1.46 (95% CI: 1.14-1.86), respectively. Stratified analyses by sex and age showed that the increased risk of death associated with severe sleep-disordered breathing was statistically significant in men aged 40-70 y (hazard ratio: 2.09; 95% CI: 1.31-3.33). Measures of sleep-related intermittent hypoxemia, but not sleep fragmentation, were independently associated with all-cause mortality. Coronary artery disease-related mortality associated with sleep-disordered breathing showed a pattern of association similar to all-cause mortality.

Conclusions: Sleep-disordered breathing is associated with all-cause mortality and specifically that due to coronary artery disease, particularly in men aged 40-70 y with severe sleep-disordered breathing. Please see later in the article for the Editors' Summary.

Citing Articles

Association of Serum Ferritin Levels With Obstructive Sleep Apnea in Overweight/Obese US Populations: A Population-Based Study From the NHANES.

Zhang Y, Zhou P, Xu C, Su H, Li R, Sun L Nat Sci Sleep. 2025; 17:223-238.

PMID: 39931349 PMC: 11807773. DOI: 10.2147/NSS.S499446.


Traditional Chinese medicine for premature ventricular contraction caused by obstructive sleep apnea: A case report and literature review.

Yue Q, Hao Y, Li T, Miao H, Chen B, Li S Medicine (Baltimore). 2025; 104(5):e41206.

PMID: 39889189 PMC: 11789912. DOI: 10.1097/MD.0000000000041206.


Development of a guide for continuous positive airway pressure use - A good fit: Making continuous positive airway pressure work for you.

Meraj A, Koep L, Baig M Can J Respir Ther. 2025; 61:7-16.

PMID: 39866656 PMC: 11760215. DOI: 10.29390/001c.127656.


Application Value of STOP-Bang Questionnaire in Predicting Abnormal Metabolites.

Pang Q, Han L, Li J, Xu L, Wang Y Diabetes Metab Syndr Obes. 2025; 18():93-99.

PMID: 39817157 PMC: 11733192. DOI: 10.2147/DMSO.S499871.


Association of Positive Airway Pressure Adherence with Clinical Outcomes in Patients with Type 2 Diabetes and Obstructive Sleep Apnea.

Bouloukaki I, Stathakis G, Moniaki V, Mavroudi E, Tsiligianni I, Schiza S Diagnostics (Basel). 2025; 14(24.

PMID: 39767142 PMC: 11674519. DOI: 10.3390/diagnostics14242781.


References
1.
Keenan S, Burt H, Ryan C, Fleetham J . Long-term survival of patients with obstructive sleep apnea treated by uvulopalatopharyngoplasty or nasal CPAP. Chest. 1994; 105(1):155-9. DOI: 10.1378/chest.105.1.155. View

2.
Shahar E, Whitney C, Redline S, Lee E, Newman A, Nieto F . Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001; 163(1):19-25. DOI: 10.1164/ajrccm.163.1.2001008. View

3.
Marin J, Carrizo S, Vicente E, Agusti A . Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005; 365(9464):1046-53. DOI: 10.1016/S0140-6736(05)71141-7. View

4.
Veale D, Chailleux E, Fleury B, Jonquet O, MICHARD P . Mortality of sleep apnoea patients treated by nasal continuous positive airway pressure registered in the ANTADIR observatory. Association Nationale pour le Traitement A Domicile de l'Insuffisance Respiratoire chronique. Eur Respir J. 2000; 15(2):326-31. DOI: 10.1034/j.1399-3003.2000.15b18.x. View

5.
Marshall N, Wong K, Liu P, Cullen S, Knuiman M, Grunstein R . Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep. 2008; 31(8):1079-85. PMC: 2542953. View